This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

MAXIMUS Helps Support DEA’s Target America: Opening Eyes To The Damage Drugs Cause Exhibit At Maryland Science Center

Stocks in this article: MMS

MAXIMUS (NYSE: MMS), a leading provider of government services worldwide, announced today that it has joined with the Drug Enforcement Administration (DEA) Museum and DEA Educational Foundation to support the Target America: Opening Eyes to the Damage Drugs Cause exhibit that is now open at the Maryland Science Center in Baltimore through September 1, 2014.

The DEA Museum’s national touring exhibit, which has been experienced by more than 22 million students, teachers and parents in nine cities across the country since 2002, is an interactive exploration of the effects of drugs on both individuals and society. It was developed in partnership with the DEA Educational Foundation, U.S. Center for Substance Abuse Prevention, U.S. National Guard, National Institute on Drug Abuse, Office of National Drug Control Policy and Partnership at Drugfree.org.

“MAXIMUS has been a long-time, generous supporter of the DEA Educational Foundation, and its involvement in Target America is very important to us,” said William Alden, the foundation’s Chairman and CEO. “The company sets the tone for others in terms of being a responsible corporate citizen. Without sponsors like MAXIMUS, there would be no Target America.”

Thomas Romeo, President of MAXIMUS Federal Services, commented, “It is our honor to again support the DEA Educational Foundation and others working to solve the devastating issue of drug abuse and addiction. Target America is a powerful exhibit that will have a lasting impact on those who experience it.”

Target America explains the science behind illegal drug addiction and the countless costs and consequences of illegal drugs to individuals, American society and the world. Visitors experience a drug investigation from start to finish, helping them understand the environmental effects of drugs and what law enforcement, drug abuse education and treatment are doing to break the troubling cycle of drugs and drug-related violence. They will view an actual South American jungle coca processing lab and a re-created Afghan heroin factory; analyze brain scans in a simulated MRI machine; and see real wreckage from a drug-related car accident. A new portion of Target America will focus specifically on Maryland and Baltimore, exploring the evolution of heroin abuse and enforcement in the area, the addiction science research taking place at Maryland universities and drug abuse prevention groups working to educate students across the state.

For more information on the content of the exhibit and related educational programs, visit www.targetamerica.org.

About MAXIMUS

MAXIMUS is a leading operator of government health and human services programs in the United States, United Kingdom, Canada, Australia and Saudi Arabia. The Company delivers business process solutions to improve the cost effectiveness, efficiency and quality of government-sponsored benefit programs, such as Medicaid, Medicare, Children's Health Insurance Program (CHIP), Health Insurance BC (British Columbia), as well as welfare-to-work and child support programs across the globe. The Company's primary customer base includes federal, provincial, state, county and municipal governments. Operating under its founding mission of Helping Government Serve the People ®, MAXIMUS has approximately 11,000 employees worldwide. For more information, visit www.maximus.com.



1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs